Evidence map›Paper›PMID 41495851›Full record

ArticleJournal of biomedical semantics2026

Annotating and indexing scientific articles with rare diseases.

Hosein Azarbonyad, Zubair Afzal, Rik Iping, Max Dumoulin, Ilse Nederveen, Jiangtao Yu, Georgios Tsatsaronis

Abstract read
In one paragraph

Article in Journal of biomedical semantics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hosein AzarbonyadElsevier B.V., Amsterdam, Noord Holland, The Netherlands. h.azarbonyad@elsevier.com.
Zubair AfzalElsevier B.V., Amsterdam, Noord Holland, The Netherlands.
Rik IpingErasmus MC, Rotterdam, Zuid Holland, The Netherlands.
Max DumoulinElsevier B.V., Amsterdam, Noord Holland, The Netherlands.
Ilse NederveenErasmus MC, Rotterdam, Zuid Holland, The Netherlands.
Jiangtao YuElsevier B.V., Amsterdam, Noord Holland, The Netherlands.
Georgios TsatsaronisElsevier B.V., Amsterdam, Noord Holland, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAround 30 million people in Europe are affected by a rare (or orphan) disease, defined as a condition occurring in fewer than 1 in 2,000 individuals. The primary challenge is to automatically and efficiently identify scientific articles and guidelines that address a particular rare disease. We present a novel methodology to annotate and index scientific text with taxonomical concepts describing rare diseases from the OrphaNet taxonomy. This task is complicated by several technical challenges, including the lack of sufficiently large, human-annotated datasets for supervised training and the polysemy/synonymy and surface-form variation of rare disease names, which can hinder any annotation engine.

resultsWe introduce a framework that operationalizes OrphaNet for large-scale literature annotation by integrating the TERMite engine with curated synonym expansion, label normalization (including deprecated/renamed concepts), and fuzzy matching. On benchmark datasets, the approach achieves precision = 92%, recall = 75%, and F1 = 83%, outperforming an string-matching baseline. Applying the pipeline to Scopus produces disease-specific corpora suitable for bibliometric and scientometric analyses (e.g., institution, country, and subject-area profiles). These outputs power the Rare Diseases Monitor dashboard for exploring national and global research activity.

conclusionTo our knowledge, this is the first systematic, scalable semantic framework for annotating and indexing rare disease literature at scale. By operationalizing OrphaNet in an automated, reproducible pipeline and addressing data scarcity and lexical variability, the work advances biomedical semantics for rare diseases and enables disease-centric monitoring, evaluation, and discovery across the research landscape.

Indexed as

Abstracting and IndexingData CurationRare DiseasesHumansSemanticsAnnotationBibliographic databasesHealth sciencesIndexingNatural language processingRare diseasesResearch applicationsScientometrics

Identifiers

PMID41495851
PMCPMC12870340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.